The final, formatted version of the article will be published soon.
SYSTEMATIC REVIEW article
Front. Immunol.
Sec. Inflammation
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1444958
Anti-inflammatory and antioxidant activity of high concentrations of hydrogen in the lung diseases: A systematic review and Meta-analysis
Provisionally accepted- 1 China Pharmaceutical University, Nanjing, Jiangsu Province, China
- 2 Shandong First Medical University, Tai'an, Shandong, China
As a small molecule, hydrogen is colorless, odorless and lightest. Many studies conducted that hydrogen can protect almost every organ, including the brain, heart muscle, liver, small intestine, and lungs. To verify whether high concentrations of hydrogen (HCH) has anti-inflammatory and antioxidant activities on respiratory system, we product a systematic review and meta-analysis. We investigated MEDLINE-PubMed, Cochrane Library, ScienceDirect, Wiley and SpringerLink database and selected in vivo studies related to the anti-inflammatory or antioxidant effects of HCH in the lung diseases which were published until September 2023. We firstly identified 437 studies and only 12 met the inclusion criteria. They all conducted in rodents. The results showed that HCH had a positive effect on the reduction of tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-4, IL-8, malondialdehyde (MDA), superoxide dismutase (SOD) and reactive oxygen species (ROS); but there is no effect on IL-6, we speculated that may contribut to the test results for different body fluids and at different points in time. This meta analysis discovered the protective effects on inflammation and oxidative stress, but whether there exists more effects on reduction of inflammatory and oxidant mediators needs to be further elucidated.
Keywords: anti-inflammatory, antioxidant, high-concentration hydrogen, metaanalysis, Respiratory System, Systematic review
Received: 06 Jun 2024; Accepted: 30 Jul 2024.
Copyright: © 2024 Xiao, Liu, Sun, Chen, Ma, Cao, Yang, Pan, Li and Du. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Kang Xiao, China Pharmaceutical University, Nanjing, 210009, Jiangsu Province, China
Jianwei Liu, Shandong First Medical University, Tai'an, 271000, Shandong, China
Shangya Chen, Shandong First Medical University, Tai'an, 271000, Shandong, China
Jiazi Ma, Shandong First Medical University, Tai'an, 271000, Shandong, China
Mao Cao, Shandong First Medical University, Tai'an, 271000, Shandong, China
Yong Yang, Shandong First Medical University, Tai'an, 271000, Shandong, China
Zhifeng Pan, Shandong First Medical University, Tai'an, 271000, Shandong, China
Peng Li, Shandong First Medical University, Tai'an, 271000, Shandong, China
Zhongjun Du, Shandong First Medical University, Tai'an, 271000, Shandong, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.